Highlights:

• Care Access’s general screening program added Lp(a) to support multiple ongoing and upcoming studies.
• Screening events in areas not reached by selected research sites on current studies, with focus on diversity and representation.
• Hundreds of physicians in Trial Access Partners program can be activated to support screening efforts.
• Research prompted the creation of value for communities, which also results in an established awareness of if/when new treatments are created.